{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:38:00Z","timestamp":1777473480557,"version":"3.51.4"},"reference-count":19,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Radiol"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p>Purpose: To evaluate the safety of adjuvant intravenous use of abciximab in balloon angioplasty for symptomatic middle cerebral artery stenosis.<\/jats:p>\n                  <jats:p>Material and Methods: Seven patients with symptomatic stenosis at the main trunk ( n\u200a=\u200a5), or proximal post-trifurcation portion ( n\u200a=\u200a2) of the middle cerebral artery, were enrolled in the study. A bolus dose of abciximab (0.15\u2005mg\/kg) was given intravenously immediately before the procedure. The immediate morphologic results as well as the presence of hyperacute thrombosis or hemorrhage after angioplasty were evaluated. Clinical evaluation was performed 1 day and 1 month following angioplasty. Oral antiplatelets were administered during the follow-up period. Follow-up angiography was performed after 7 to 14 (mean 10.4) months. Stenosis of a vessel greater than 50% was considered as restenosis.<\/jats:p>\n                  <jats:p>Results: The procedure was technically successful in all patients. Immediate residual stenosis was insignificant in 4 and mild (less than 50%) in 3 patients. There was no evidence of intimal dissection. Mild gum bleeding was noted in two patients. All study patients were clinically stable at follow-up without newly developed neurological abnormality even though there was one case of occlusion and one case of restenosis on follow-up angiography. Angiographic patency rate was 71%.<\/jats:p>\n                  <jats:p>Conclusion: In performing proximal middle cerebral artery balloon angioplasty, abciximab may be safely used to prevent acute thrombosis. The mid-term patency of the vessels was also acceptable.<\/jats:p>","DOI":"10.1080\/02841850510021535","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T11:16:40Z","timestamp":1126091800000},"page":"534-538","source":"Crossref","is-referenced-by-count":1,"title":["Adjuvant use of abciximab for balloon angioplasty of symptomatic middle cerebral artery stenosis"],"prefix":"10.1177","volume":"46","author":[{"given":"D. H.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Radiology, Asan Medical Center and Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Asan Medical Center and Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","volume":"284","author":"Bhatt D. L.","year":"2000","unstructured":"Bhatt, D. L. and Topol, E. J. (2000) Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes. <i>J Am Med Assoc<\/i>, 284, pp. 1549 - 58.","journal-title":"J Am Med Assoc"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.STR.26.7.1200","volume":"26","author":"Clark W. M.","year":"1995","unstructured":"Clark, W. M. and Barnwell, S. L. and Nesbit, G. and O'Neill, O. R. and Wynn, M. L. and Coull, B. M. (1995) Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. <i>Stroke<\/i>, 26, pp. 1200 - 4.","journal-title":"Stroke"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0002-8703(96)90442-1","volume":"132","author":"Dangas G.","year":"1996","unstructured":"Dangas, G. and Fuster, V. (1996) Management of restenosis after coronary intervention. <i>Am Heart J<\/i>, 132, pp. 428 - 36.","journal-title":"Am Heart J"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"EPIC Investigators","year":"1994","unstructured":"EPIC Investigators. (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high\u2010risk coronary angioplasty. The EPIC Investigation. <i>N Engl J Med<\/i>, 330, pp. 956 - 61.","journal-title":"N Engl J Med"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jnnp.2003.019570","volume":"75","author":"Kim J. K.","year":"2004","unstructured":"Kim, J. K. and Ahn, J. Y. and Lee, B. H. and Chung, Y. S. and Chung, S. S. and Kim, O. J. and (2004) Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short\u2010term arteriographical and clinical outcome. <i>J Neurol Neurosurg Psychiatry<\/i>, 75, pp. 847 - 51.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1259\/bjr\/89933527","volume":"77","author":"Lee D. H.","year":"2004","unstructured":"Lee, D. H. and Ahn, J. H. and Jeong, S. S. and Eo, K. S. and Park, M. S. (2004) Routine transradial access for conventional cerebral angiography: a single operator's experience of its feasibility and safety. <i>Br J Radiol<\/i>, 77, pp. 831 - 8.","journal-title":"Br J Radiol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000067135","volume":"15","author":"Lee J. H.","year":"2003","unstructured":"Lee, J. H. and Kwon, S. U. and Suh, D. C. and Kim, J. S. (2003) Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long\u2010term follow\u2010up. <i>Cerebrovasc Dis<\/i>, 15, pp. 90 - 7.","journal-title":"Cerebrovasc Dis"},{"key":"E00008","first-page":"1525","volume":"19","author":"Mori T.","year":"1998","unstructured":"Mori, T. and Fukuoka, M. and Kazita, K. and Mori, K. (1998) Follow\u2010up study after intracranial percutaneous transluminal cerebral balloon angioplasty. <i>Am J Neuroradiol<\/i>, 19, pp. 1525 - 33.","journal-title":"Am J Neuroradiol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002340050376","volume":"39","author":"Mori T.","year":"1997","unstructured":"Mori, T. and Mori, K. and Fukuoka, M. and Arisawa, M. and Honda, S. (1997) Percutaneous transluminal cerebral angioplasty: serial angiographic follow\u2010up after successful dilatation. <i>Neuroradiology<\/i>, 39, pp. 111 - 16.","journal-title":"Neuroradiology"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002340050370","volume":"39","author":"Mori T.","year":"1997","unstructured":"Mori, T. and Mori, K. and Fukuoka, M. and Honda, S. (1997) Percutaneous transluminal angioplasty for total occlusion of middle cerebral arteries. <i>Neuroradiology<\/i>, 39, pp. 71 - 4.","journal-title":"Neuroradiology"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.suc.2004.05.003","volume":"84","author":"Nelken N.","year":"2004","unstructured":"Nelken, N. and Schneider, P. A. (2004) Advances in stent technology and drug\u2010eluting stents. <i>Surg Clin North Am<\/i>, 84, pp. 1203 - 36.","journal-title":"Surg Clin North Am"},{"key":"E00012","first-page":"878","volume":"11","author":"Purdy P. D.","year":"1990","unstructured":"Purdy, P. D. and Devous, M. D., Sr. and Unwin, D. H. and Giller, C. A. and Batjer, H. H. (1990) Angioplasty of an atherosclerotic middle cerebral artery associated with improvement in regional cerebral blood flow. <i>Am J Neuroradiol<\/i>, 11, pp. 878 - 80.","journal-title":"Am J Neuroradiol"},{"key":"E00013","first-page":"466","volume":"50","author":"Qureshi A. I.","year":"2002","unstructured":"Qureshi, A. I. and Suri, M. F. and Ali, Z. and Kim, S. H. and Lanzino, G. and Fessler, R. D. and (2002) Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab. <i>Neurosurgery<\/i>, 50, pp. 466 - 73.","journal-title":"Neurosurgery"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","volume":"96","author":"RESTORE Investigators","year":"1997","unstructured":"RESTORE Investigators. (1997) Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. <i>Circulation<\/i>, 96, pp. 1445 - 53.","journal-title":"Circulation"},{"key":"E00015","first-page":"1147","volume":"25","author":"Song J. K.","year":"2004","unstructured":"Song, J. K. and Niimi, Y. and Fernandez, P. M. and Brisman, J. L. and Buciuc, R. and Kupersmith, M. J. and (2004) Thrombus formation during intracranial aneurysm coil placement: treatment with intra\u2010arterial abciximab. <i>Am J Neuroradiol<\/i>, 25, pp. 1147 - 53.","journal-title":"Am J Neuroradiol"},{"key":"E00016","first-page":"553","volume":"20","author":"Suh D. C.","year":"1999","unstructured":"Suh, D. C. and Sung, K. B. and Cho, Y. S. and Choi, C. G. and Lee, H. K. and Lee, J. H. and (1999) Transluminal angioplasty for middle cerebral artery stenosis in patients with acute ischemic stroke. <i>Am J Neuroradiol<\/i>, 20, pp. 553 - 8.","journal-title":"Am J Neuroradiol"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3171\/jns.1995.82.6.0953","volume":"82","author":"Toucho H.","year":"1995","unstructured":"Toucho, H. (1995) Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. <i>J Neurosurg<\/i>, 82, pp. 953 - 60.","journal-title":"J Neurosurg"},{"key":"E00018","first-page":"33","volume":"10","author":"Wholey M. H.","year":"2003","unstructured":"Wholey, M. H. and Eles, G. and Toursakissian, B. and Bailey, S. and Jarmolowski, C. and Tan, W. A. (2003) Evaluation of glycoprotein IIb\/IIIa inhibitors in carotid angioplasty and stenting. <i>J Endovasc Ther<\/i>, 10, pp. 33 - 41.","journal-title":"J Endovasc Ther"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s002340050651","volume":"40","author":"Yokote H.","year":"1998","unstructured":"Yokote, H. and Terada, T. and Ryujin, K. and Konoshita, Y. and Tsuura, M. and Nakai, E. and (1998) Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. <i>Neuroradiology<\/i>, 40, pp. 590 - 6.","journal-title":"Neuroradiology"}],"container-title":["Acta Radiologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/02841850510021535","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/02841850510021535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:46:58Z","timestamp":1777384018000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1080\/02841850510021535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1080\/02841850510021535"],"URL":"https:\/\/doi.org\/10.1080\/02841850510021535","relation":{},"ISSN":["0284-1851","1600-0455"],"issn-type":[{"value":"0284-1851","type":"print"},{"value":"1600-0455","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}